Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Depreciation & Amortization (CF): 2024-2025

Historic Depreciation & Amortization (CF) for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to $527,000.

  • Pyxis Oncology's Depreciation & Amortization (CF) fell 27.91% to $527,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year change of. This contributed to the annual value of $3.0 million for FY2024, which is 54.75% up from last year.
  • According to the latest figures from Q3 2025, Pyxis Oncology's Depreciation & Amortization (CF) is $527,000, which was down 1.50% from $535,000 recorded in Q2 2025.
  • In the past 5 years, Pyxis Oncology's Depreciation & Amortization (CF) ranged from a high of $1.1 million in Q1 2024 and a low of $527,000 during Q3 2025.
  • Over the past 2 years, Pyxis Oncology's median Depreciation & Amortization (CF) value was $552,000 (recorded in 2025), while the average stood at $656,571.
  • Data for Pyxis Oncology's Depreciation & Amortization (CF) shows a maximum YoY plummeted of 50.54% (in 2025) over the last 5 years.
  • Over the past 2 years, Pyxis Oncology's Depreciation & Amortization (CF) (Quarterly) stood at $550,000 in 2024, then dropped by 27.91% to $527,000 in 2025.
  • Its Depreciation & Amortization (CF) stands at $527,000 for Q3 2025, versus $535,000 for Q2 2025 and $552,000 for Q1 2025.